Nomilin
Nomilin is an inducer of phase II detoxifying enzymes, showing anti-proliferative active on cultured human breast cancer cells. (In Vitro) :Nomilin treatment significantly mitigated cell death and decreased lactate dehydrogenase (LDH) release and ROS production in SH-SY5Y cells induced by oxygen-glucose deprivation (OGD), which was almost abolished by Nrf2 knockdown. (In Vivo) :Nomilin attenuated blood-brain barrier (BBB) disruption in MCAO rats, which might be associated with alleviating the loss of tight junction proteins, including ZO-1 and occludin-5.
Product Specifications
CAS Number
1063-77-0
Product Name Alternative
Nomilin
Purity
>98% (HPLC)
Solubility
In Vitro: DMSO : 100 mg/mL (194.34 mM)
Smiles
CC (=O) OC5CC (=O) O[C@@] (C) (C) [C@@H]6CC (=O) [C@]3 (C) [C@H] (CC[C@@]2 (C) [C@@H] (OC (=O) [C@H]1O[C@]123) c4ccoc4) [C@@]56C
Molecular Formula
C28H34O9
Molecular Weight
514.57
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
1- (Acetyloxy) -1,2-dihydroobacunoic acid e-lactone
Available Sizes
Explore Other Products
Browse additional items from our catalog
Human Suppressor of tumorigenicity 14 protein (ST14) ELISA Kit
Human Suppressor of tumorigenicity 14 protein (ST14) ELISA Kit
Human Suppressor of tumorigenicity 14 protein (ST14) ELISA Kit
Human Suppressor of tumorigenicity 14 protein (ST14) ELISA Kit
Ghr Mouse shRNA Lentiviral Particle (Locus ID 14600)
